Atai Life Sciences Stock

Wealthy Biotech Trader

MindMed (NADSAQ: MNMD) Down 15% on FDA Development

MindMed, a company specializing in psychedelic medicine, experienced a significant drop in its stock price, falling 15% following news regarding…

Read More »
Back to top button